Physician profile
Patrick A Mceneaney
NPI 1174613319
$570,071.31
in general payments reported to CMS, 2019-2025
70 companies · $85K in 2025
The $85K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $29K · 2021: $140K · 2022: $43K · 2023: $62K · 2024: $140K · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $94K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $80K · Consulting Fee: $25K · Charitable Contribution: $25K · Food and Beverage: $20K · Travel and Lodging: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Education: $9,772 · Other payment types: $8,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $94,311.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $79,612.50 |
| Consulting Fee | $25,084.08 |
| Charitable Contribution | $25,000.00 |
| Food and Beverage | $19,545.23 |
| Travel and Lodging | $14,398.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,467.65 |
| Education | $9,771.83 |
| Other payment types | $8,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $190,714.87 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $119,574.51 | 2022-2025 | Motoband, Hammerlock, Fibergraft Bg Morsels |
| Medshape, INC. | $115,390.88 | 2019-2023 | Dynanail |
| Crossroads Extremity Systems, LLC | $67,832.24 | 2019-2021 | |
| Biotissue Holdings INC. | $15,142.90 | 2019-2022 | |
| Stryker Corporation | $14,341.37 | 2019-2025 | Inbone, Citrefix, Hoffmann |
| Biocomposites INC | $12,445.21 | 2019-2025 | Stimulan, Stimulan |
| Innovation Technologies INC | $11,377.14 | 2019-2025 | Irrisept |
| Synthes USA Products LLC | $8,190.39 | 2023 | |
| Surgenex LLC | $1,629.27 | 2025 | Renograft, Surgraft, Surmatrix |
| In2bones USA, LLC | $1,512.65 | 2021-2022 | |
| Medline Industries LP | $1,212.40 | 2019-2020 | |
| Restor3d, INC. | $1,125.00 | 2019-2021 | |
| Treace Medical Concepts, INC. | $692.64 | 2024-2025 | |
| Anika Therapeutics, INC. | $621.31 | 2021-2024 | Integrity, Glenojet, Ovo Motion |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $546.73 | 2019-2020 | |
| Smith+Nephew, INC. | $473.89 | 2022-2025 | Oasis, Grafix Pl, Stravix |
| Dunamis Medical, LLC | $393.63 | 2025 | |
| Zimmer Biomet Holdings, INC. | $382.17 | 2019-2021 | |
| Medela LLC | $373.58 | 2020-2023 | Invia Motion Endure |
| Ortho Solutions INC | $360.34 | 2024-2025 | |
| Osteomed LLC | $353.92 | 2019-2022 | |
| Linvatec Corporation | $350.52 | 2024-2025 | Biobrace 23mm, Fracture and Correction Colag 2, Allograft Tissue |
| Abbott Laboratories | $347.87 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $340.16 | 2019-2021 | |
| Acera Surgical, INC. | $288.49 | 2019-2022 | |
| Medtronic, INC. | $267.27 | 2021-2024 | Venaseal |
| Aroa Biosurgery Incorporated | $222.00 | 2023-2024 | |
| Axogen | $219.20 | 2020-2025 | Axoguard Ha+ Nerve Protector |
| Bone Support INC. | $201.22 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Miach Orthopaedics, INC. | $183.28 | 2024 | |
| Fusion Orthopedics USA, LLC | $175.85 | 2023-2025 | |
| Organogenesis INC. | $167.47 | 2020-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $147.53 | 2019-2025 | Nuzyra |
| Ossdsign USA Incorporated | $146.25 | 2024 | |
| Celularity INC. | $145.53 | 2019-2020 | |
| Nevro Corp. | $128.99 | 2019-2022 | |
| Misonix INC | $128.56 | 2020 | |
| Melinta Therapeutics, LLC | $125.00 | 2021 | |
| Flower Orthopedics Coporation | $124.28 | 2025 | |
| Integra Lifesciences Corporation | $122.47 | 2019-2020 | |
| Reapplix INC. | $118.59 | 2025 | 3c Patch Kit - Box |
| Encore Medical, LP | $112.29 | 2021-2022 | |
| Baudax Bio INC. | $108.02 | 2020 | |
| Osiris Therapeutics INC. | $107.69 | 2019 | |
| Orthofix Medical, INC. | $91.83 | 2022 | |
| Paragon 28, INC. | $90.03 | 2022-2025 | Portfolio |
| Globus Medical, INC. | $89.70 | 2024 | Harvest |
| Acumed LLC | $86.45 | 2023 | Acumed, Osteomed |
| Djo, LLC | $62.65 | 2022-2025 | Cmf |
| Horizon Therapeutics Plc | $60.86 | 2021-2023 | Krystexxa |
| Wright Medical Technology, INC. | $60.39 | 2019-2020 | |
| Trice Medical, INC. | $59.45 | 2024 | |
| Vaporox, INC. | $53.60 | 2023 | Vht-200 Wound Treatment System |
| Next Science LLC | $48.54 | 2023 | Surgx, Xperience, Blastx |
| Amgen INC. | $41.58 | 2025 | Krystexxa |
| Fidia Pharma USA INC. | $40.03 | 2020-2023 | Triluron, Hymovis |
| Heron Therapeutics, INC. | $39.97 | 2021-2023 | Zynrelef |
| Kci USA, INC. | $39.55 | 2022-2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Urgo Medical North America, LLC | $37.28 | 2024 | Urgoclean Ag |
| Bioventus LLC | $30.00 | 2025 | Exogen Ultrasound Bone Healing System |
| Ets Wound Care LLC | $23.03 | 2024 | Mirragen Advanced Wound Matrix |
| Ethicon US, LLC | $22.89 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.26 | 2025 | |
| Solventum Corporation | $20.87 | 2024 | Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $18.00 | 2019 | |
| Omeza LLC | $17.94 | 2023 | |
| Molnlycke Health Care US, LLC | $17.91 | 2025 | Exufiber Ag+, Mepilex Border Flex, Mepitel One |
| Highridge Medical LLC | $16.12 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Zimvie INC. | $15.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,131.39 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$313,912.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mceneaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.